Biocon Ltd.

NSE: BIOCON | BSE: 532523 | ISIN: INE376G01013 | Industry: Biotechnology
| Mid-range Performer
383.1000 -8.30 (-2.12%)
NSE Aug 01, 2025 15:31 PM
Volume: 3.1M
 

383.10
-2.12%
Sharekhan
Revenues stood at Rs. 3,590 crore, up 4% y-o-y and a 5% rise q-o-q. EBITDA reached Rs. 730 crore, down 1% y-o-y but up 24% q-o-q. PAT stood at Rs. 27 crore, a decline of 84% y-o-y and 97% q-o-q.
Promoters have decreased holdings from 60.64% to 54.45% in Jun 2025 qtr
More from Biocon Ltd.
Recommended